Subtype
Malignant Male Reproductive System Neoplasm
CI-CAN-00003180Explore in graph →
1,451 active trials27 approved drugs58 evidence items
- NCIt
- C8561
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00003180Explore in graph →
Clinical trials
6,227 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (762)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06134232 | Metastatic Castrate-Resistant Prostate Cancer Subjects Treated With PROVENGE® + One Infusion of Sipuleucel-T(ProvONE) | recruiting | Phase 2 | 400 | DendreonINDUSTRY | 1 | Aug 27, 2025 | clinicaltrials |
| NCT06241846 | A Phase II Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of YL201 in Patients With mCRPC | recruiting | Phase 2 | 100 | MediLink Therapeutics (Suzhou) Co., Ltd.INDUSTRY | 1 | Aug 27, 2025 |
| clinicaltrials |
| NCT06683846 | Ivonescimab in the Treatment of Multiple Advanced Tumors | recruiting | Phase 2 | 400 | Fudan UniversityOTHER | 1 | Aug 24, 2025 | clinicaltrials |
| NCT03385655 | Prostate Cancer Biomarker Enrichment and Treatment Selection | active not recruiting | Phase 2 | 200 | Canadian Cancer Trials GroupNETWORK | 1 | Aug 21, 2025 | clinicaltrials |
| NCT04319783 | Darolutamide + Consolidation Radiotherapy in Advanced Prostate Cancer Detected by PSMA(DECREASE) | active not recruiting | Phase 2 | 65 | Trans Tasman Radiation Oncology GroupOTHER | 2 | Aug 21, 2025 | clinicaltrials |
| NCT05576766 | Enhanced Recovery After Surgery (ERAS) Pathway in Patients Undergoing Robot-Assisted Laparoscopic Radical Prostatectomy | not yet recruiting | N/A | 54 | Peking University First HospitalOTHER | 1 | Aug 21, 2025 | clinicaltrials |
| NCT06824259 | The Value of Dual-parametric Magnetic Resonance Combined With Regional Saturation Biopsy in Patients With Suspected Prostate Cancer | active not recruiting | N/A | 400 | Peking University First HospitalOTHER | 1 | Aug 21, 2025 | clinicaltrials |
| NCT07134439 | Identifying Fundamental Mechanisms of Skeletal Muscle Ageing in Older Men Undergoing Androgen Deprivation Therapy: a Feasibility Study(MASS-ADT) | not yet recruiting | — | 20 | Guy's and St Thomas' NHS Foundation TrustOTHER | 0 | Aug 21, 2025 | clinicaltrials |
| NCT04015622 | PROstate Cancer TReatment Optimization Via Analysis of Circulating Tumour DNA(PROTRACT) | active not recruiting | Phase 2 | 100 | British Columbia Cancer AgencyOTHER | 1 | Aug 20, 2025 | clinicaltrials |
| NCT05802121 | Akkermansia Muciniphilia and Metabolic Side Effects of ADT | recruiting | Early Phase 1 | 30 | Western UniversityOTHER | 1 | Aug 20, 2025 | clinicaltrials |
| NCT07015138 | Comprehensive Versus Primary Tumor Radiotherapy in Oligometastatic Prostate Cancer(PROLONG-3) | recruiting | N/A | 390 | Peking University First HospitalOTHER | 1 | Aug 20, 2025 | clinicaltrials |
| NCT07132658 | MRI-guided Ultrahypofractionated SBRT Prostate Program | not yet recruiting | N/A | 40 | Clinica Universidad de Navarra, Universidad de NavarraOTHER | 0 | Aug 20, 2025 | clinicaltrials |
| NCT07132671 | MRI-guided Brachytherapy and Salvage SBRT Program | not yet recruiting | N/A | 29 | Clinica Universidad de Navarra, Universidad de NavarraOTHER | 0 | Aug 20, 2025 | clinicaltrials |
| NCT05645237 | HRQOL in Prostate Cancer Patients Treated With Radiotherapy(PRORAD) | active not recruiting | — | 600 | Erasmus Medical CenterOTHER | 1 | Aug 19, 2025 | clinicaltrials |
| NCT07130708 | Exploring the Potential of Robotic Telesurgery in Remote Settings | recruiting | N/A | 10 | AdventHealthOTHER | 1 | Aug 19, 2025 | clinicaltrials |
| NCT01990196 | Neoadjuvant Phase 2 Study Comparing the Effects of AR Inhibition With/Without SRC or MEK Inhibition in Prostate Cancer | active not recruiting | Phase 2 | 45 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Aug 17, 2025 | clinicaltrials |
| NCT02766543 | Pivotal Study of MRI-guided Transurethral Ultrasound Ablation in Patients With Localized Prostate Cancer(TACT) | active not recruiting | N/A | 150 | Profound Medical Inc.OTHER | 5 | Aug 17, 2025 | clinicaltrials |
| NCT03170960 | Study of Cabozantinib Alone or in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors | active not recruiting | Phase 1 | 914 | ExelixisINDUSTRY | 9 | Aug 17, 2025 | clinicaltrials |
| NCT03630666 | Comparison of Intermittent Androgen Deprivation Therapy With or Without Irradiation Recovery in Prostate Cancer Patients(OLIGOPELVIS2) | active not recruiting | N/A | 256 | Institut Cancerologie de l'OuestOTHER | 1 | Aug 17, 2025 | clinicaltrials |
| NCT05027477 | A Comparison of TULSA Procedure vs. Radical Prostatectomy in Participants With Localized Prostate Cancer(CAPTAIN) | active not recruiting | N/A | 201 | Profound Medical Inc.OTHER | 3 | Aug 17, 2025 | clinicaltrials |
| NCT07126093 | High-intensity Focused Ultrasound Combined With Novel Hormone Therapy in Advanced Prostate Cancer(HIFU NHT PCa) | not yet recruiting | N/A | 134 | Shanghai General Hospital, Shanghai Jiao Tong University School of MedicineOTHER | 0 | Aug 17, 2025 | clinicaltrials |
| NCT06424275 | Prostate Cancer Awareness and Initiative for Screening in the European Union(PRAISE-U) | enrolling by invitation | — | 20,000 | European Association of Urology Research FoundationOTHER | 4 | Aug 15, 2025 | clinicaltrials |
| NCT07112781 | Feasibility Trial of Single-Dose Radiotherapy for Localized Low and Intermediate Risk Prostate Cancer(FAST-ONE) | recruiting | N/A | 30 | Branch Office of "Hadassah Medical Ltd"OTHER | 1 | Aug 13, 2025 | clinicaltrials |
| NCT06220435 | Tumor-directed Radiation Therapy for Patients With the Highest Risk Category of Localized Prostate Cancer | recruiting | N/A | 76 | Region SkaneOTHER | 1 | Aug 12, 2025 | clinicaltrials |
| NCT07118436 | Liquid Biopsy Under PSMA Radioligand Therapy(LOOPS) | recruiting | — | 100 | Wuerzburg University HospitalOTHER | 1 | Aug 12, 2025 | clinicaltrials |
| NCT05057013 | A Phase I/IIa Trial of HMBD-001 in Advanced HER3 Positive Solid Tumours | active not recruiting | Phase 1 / Phase 2 | 81 | Cancer Research UKOTHER | 1 | Aug 11, 2025 | clinicaltrials |
| NCT07115277 | Diagnostic Efficacy and Safety of Flotufolastat F-18 Injection in Subjects With Biochemical Recurrence of Prostate Cancer | recruiting | N/A | 121 | Sinotau Pharmaceutical GroupINDUSTRY | 1 | Aug 11, 2025 | clinicaltrials |
| NCT05885009 | Feasibility and Impact of Liquid Biopsy Genomic Profiling on Treatment Patients With Metastatic Prostate Cancer in Spain (SOLTI-2102)(HOPE-PROSTATE) | recruiting | — | 240 | SOLTI Breast Cancer Research GroupOTHER | 1 | Aug 6, 2025 | clinicaltrials |
| NCT07104617 | Study of TY-302 Capsules Combined With Abiraterone in Patients With Metastatic Castration-resistant Prostate Cancer（mCRPC） | not yet recruiting | Phase 1 / Phase 2 | 48 | TYK Medicines, IncINDUSTRY | 1 | Aug 5, 2025 | clinicaltrials |
| NCT07101731 | Effects of Hypopressive Exercises on Urinary Incontinence and Erectile Dysfunction After Radical Prostatectomy | recruiting | N/A | 30 | Bartın UnıversityOTHER | 1 | Aug 3, 2025 | clinicaltrials |
| NCT07101822 | A PHASE II, RANDOMIZED STUDY TO ASSESS MAINTENANCE THERAPY WITH CEMIPLIMAB VERSUS BEST SUPPORTIVE CARE AFTER 1ST LINE PLATINUM-BASED CHEMOTHERAPY IN ADVANCED/RECURRENT PENILE CANCER(BRAVA PENILE) | not yet recruiting | Phase 2 | 42 | Hospital Israelita Albert EinsteinOTHER | 1 | Aug 3, 2025 | clinicaltrials |
| NCT03830788 | Erectile Dysfunction in Good Prognosis Prostate Cancer : Comparison Between Brachytherapy and Stereotactic Body Radiotherapy(TEMPOS) | recruiting | N/A | 240 | Center Eugene MarquisOTHER | 1 | Aug 1, 2025 | clinicaltrials |
| NCT06462963 | OligoCare TwiCs (Trials Within Cohorts) Trial Comparing Acute Toxicity in Single-fraction vs Multiple-fraction SBRT for Metastasis-directed Treatment (SPRINT)(SPRINT) | recruiting | N/A | 302 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 4 | Aug 1, 2025 | clinicaltrials |
| NCT06691776 | Feasibility of CBCT-Guided Online Adaptive Radiotherapy (FASCINATE)(FASCINATE) | recruiting | N/A | 100 | The Netherlands Cancer InstituteOTHER | 1 | Aug 1, 2025 | clinicaltrials |
| NCT07032584 | Impact of Multimodal Telerehabilitation in Rural Patients With Metastatic Prostate Cancer | recruiting | N/A | 74 | University of UtahOTHER | 1 | Aug 1, 2025 | clinicaltrials |
| NCT07096596 | Prostate Cancer Study of Patient Experiences(PROSPEX) | not yet recruiting | — | 3,000 | Ankara UniversityOTHER | 1 | Jul 31, 2025 | clinicaltrials |
| NCT01436968 | Phase 3 Study of ProstAtak® Immunotherapy With Standard Radiation Therapy for Localized Prostate Cancer(PrTK03) | active not recruiting | Phase 3 | 711 | Candel Therapeutics, Inc.INDUSTRY | 2 | Jul 30, 2025 | clinicaltrials |
| NCT01952223 | A Phase III of Cabazitaxel and Pelvic Radiotherapy in Localized Prostate Cancer and High-risk Features of Relapse(PEACE2) | active not recruiting | Phase 3 | 761 | UNICANCEROTHER | 1 | Jul 30, 2025 | clinicaltrials |
| NCT02768363 | Randomized Controlled Trial of CAN-2409 Immunotherapy During Active Surveillance for Prostate Cancer (ULYSSES) | active not recruiting | Phase 2 | 187 | Candel Therapeutics, Inc.INDUSTRY | 2 | Jul 30, 2025 | clinicaltrials |
| NCT04181203 | Combined Apalutamide, Radiotherapy, and LHRH Agonist in Prostate Cancer Patients After Prostatectomy(CARLHA-2) | active not recruiting | Phase 3 | 490 | UNICANCEROTHER | 1 | Jul 30, 2025 | clinicaltrials |
| NCT05269550 | PSMA MRI Guided Prostate SBRT (ARGOS)/Comprehensive, Longitudinal Evaluation of Imaging Biomarkers Post Radiotherapy (CLIMBER)(ARGOS/CLIMBER) | active not recruiting | N/A | 50 | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph'sOTHER | 1 | Jul 28, 2025 | clinicaltrials |
| NCT02543905 | The PROFILE Study: Germline Genetic Profiling: Correlation With Targeted Prostate Cancer Screening and Treatment(PROFILE) | recruiting | — | 1,600 | Institute of Cancer Research, United KingdomOTHER | 1 | Jul 25, 2025 | clinicaltrials |
| NCT05574647 | Imperial Prostate 7 - Prostate Assessment Using Comparative Interventions - Fast Mri and Image-fusion for Cancer(IP7-PACIFIC) | recruiting | N/A | 3,600 | Imperial College LondonOTHER | 1 | Jul 24, 2025 | clinicaltrials |
| NCT06666270 | Study of SYN818 for the Treatment of Advanced or Metastatic Solid Tumors | recruiting | Phase 1 | 30 | Hangzhou SynRx Therapeutics Biomedical Technology Co., LtdINDUSTRY | 1 | Jul 20, 2025 | clinicaltrials |
| NCT06932458 | A Clinical Trial of Primary Retroperitoneal Lymph Node Dissection in Patients With Testicular Seminoma With Limited Retroperitoneal Metastases(RPLND-Seminoma) | recruiting | Phase 2 | 30 | Western University, CanadaOTHER | 1 | Jul 20, 2025 | clinicaltrials |
| NCT05882253 | Prostate Cancer IMAGing IN Early Detection (IMAGINED Trial)(IMAGINED) | recruiting | N/A | 225 | University of California, San DiegoOTHER | 1 | Jul 17, 2025 | clinicaltrials |
| NCT06954233 | Voiding and Erectile Function After Retroperitoneal Lymph Node Dissection for Testicular Cancer(VEEF-RPLND-TC) | recruiting | — | 20 | Jagiellonian UniversityOTHER | 1 | Jul 16, 2025 | clinicaltrials |
| NCT07064811 | Standardized Resistance Training Program and Assessment System for Prostate Cancer Patients Receiving Androgen Deprivation Therapy ISPoRT-PCa-ADT Study Protocol for a Randomized Controlled Trial. SPORT-MU(SPORT-MU) | not yet recruiting | N/A | 60 | Fundacion para la Formacion e Investigacion Sanitarias de la Region de MurciaOTHER | 1 | Jul 15, 2025 | clinicaltrials |
| NCT04404894 | Long-Term Prospective Registry in Prostate Cancer Patients From Diverse Urology Practice Settings Following Prolaris® Testing | active not recruiting | — | 500 | Myriad Genetic Laboratories, Inc.INDUSTRY | 1 | Jul 14, 2025 | clinicaltrials |
Data updated 23 days agoSource updated Aug 27, 2025source: clinicaltrials